Nura Vietnam cooperates with MSIG Vietnam to provide health insurance

Screeners at Nura can access the MSIG Care health insurance product with a variety of benefits, medical facility options and coverage in Asia.

The information was announced at the cooperation announcement ceremony of T-Matsuoka Nura Vietnam Health System and MSIG Vietnam Non-Life Insurance Company Limited, taking place on September 10 in Hanoi.

According to the agreement, the two parties coordinate to introduce the MSIG Care health insurance product to customers. The product has multiple levels of benefits, allowing you to choose from medical facilities and insurance coverage in Asia. Specific benefits depend on the terms, conditions and scope of the program the customer participates in.

Talking about the meaning of the cooperation program, Mr. Yoshinori Ito, General Director of MSIG Vietnam, assessed that the cooperation helps screening customers at Nura to more conveniently access health insurance products with many levels of benefits and choose medical facilities and insurance coverage in Asia.

A representative of Nura Vietnam said that after screening, some customers may need monitoring, intensive examination or treatment. Besides medical orientation, financial preparation can affect each family's health care choices and plans. Based on this need, the referral unit cooperates with MSIG, helping customers learn about programs that suit their needs and financial capabilities.

Mr. Nguyen Huy Tuan, President of T-Matsuoka Health System and Nura Vietnam, expects that cooperation will help customers prepare earlier for health care needs and possible costs that may arise.

Nura is a specialized health screening model of the global Nura system, present in 12 countries. In Vietnam, the system has three facilities in Hanoi and Ho Chi Minh City, focusing on screening for cancer and lifestyle diseases before obvious symptoms appear. From July 1, 2024 to mid-August 2026, the system has screened more than 42,000 customers, recorded 71,633 health problems that need attention and nearly 200 cancer cases detected at an early stage.